Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway

被引:287
作者
Miao, H
Wei, BR
Peehl, DM
Li, Q
Alexandrou, T
Schelling, JR
Rhim, JS
Sedor, JR
Burnett, E
Wang, BC
机构
[1] Case Western Reserve Univ, Sch Med, Rammelkamp Ctr Res, Cleveland, OH 44109 USA
[2] Case Western Reserve Univ, Sch Med, Ireland Canc Ctr, Cleveland, OH 44109 USA
[3] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44109 USA
[4] Stanford Univ, Dept Urol, Stanford, CA 94305 USA
[5] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/35074604
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interactions between Eph receptor tyrosine kinases (RTKs) and membrane-anchored ephrin ligands critically regulate axon pathfinding and development of the cardiovascular system, as well as migration of neural cells. Similar to other RTKs, ligand-activated Eph kinases recruit multiple signalling and adaptor proteins, several of which are involved in growth regulation(1,2). However, in contrast to other RTKs, activation of Eph receptors fails to promote cell proliferation(3,4) or to transform rodent fibroblasts(5), indicating that Eph kinases may initiate signalling pathways that are distinct from those transmitted by other RTKs. Here we show that stimulation of endogenous EphA kinases with ephrin-A1 potently inhibits the Ras/MAPK cascade in a range of cell types, and attenuates activation of mitogen-activated protein kinase (MAPK) by receptors for platelet-derived growth factor (PDGF), epidermal growth factor (EGF) and Vascular endothelial growth factor (VEGF). In prostatic epithelial cells and endothelial cells, but not fibroblasts, treatment with ephrin-A1 inhibits cell proliferation. Our results identify EphA kinases as negative regulators of the Ras/MAPK pathway that exert anti-mitogenic functions in a cell-type-specific manner.
引用
收藏
页码:527 / 530
页数:4
相关论文
共 25 条
[1]   BINDING OF SH2 DOMAINS OF PHOSPHOLIPASE-C-GAMMA-1, GAP, AND SRC TO ACTIVATED GROWTH-FACTOR RECEPTORS [J].
ANDERSON, D ;
KOCH, CA ;
GREY, L ;
ELLIS, C ;
MORAN, MF ;
PAWSON, T .
SCIENCE, 1990, 250 (4983) :979-982
[2]   MEMBRANE-BOUND LERK2 LIGAND CAN SIGNAL THROUGH 3 DIFFERENT EPH-RELATED RECEPTOR TYROSINE KINASES [J].
BRAMBILLA, R ;
SCHNAPP, A ;
CASAGRANDA, F ;
LABRADOR, JP ;
BERGEMANN, AD ;
FLANAGAN, JG ;
PASQUALE, EB ;
KLEIN, R .
EMBO JOURNAL, 1995, 14 (13) :3116-3126
[3]   Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation [J].
Brondello, JM ;
Pouysségur, J ;
McKenzie, FR .
SCIENCE, 1999, 286 (5449) :2514-2517
[4]   Functional activation of EphA5 receptor does not promote cell proliferation in the aberrant EphA5 expressing human glioblastoma U-118 MG cell line [J].
Bruce, V ;
Olivieri, G ;
Eickelberg, O ;
Miescher, GC .
BRAIN RESEARCH, 1999, 821 (01) :169-176
[5]   Signaling by Eph receptors and their ephrin ligands [J].
Brückner, K ;
Klein, R .
CURRENT OPINION IN NEUROBIOLOGY, 1998, 8 (03) :375-382
[6]   Ephrins and their receptors: a repulsive topic? [J].
Gale, NW ;
Yancopoulos, GD .
CELL AND TISSUE RESEARCH, 1997, 290 (02) :227-241
[7]   Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis [J].
Gale, NW ;
Holland, SJ ;
Valenzuela, DM ;
Flenniken, A ;
Pan, L ;
Ryan, TE ;
Henkemeyer, M ;
Strebhardt, K ;
Hirai, H ;
Wilkinson, DG ;
Pawson, T ;
Davis, S ;
Yancopoulos, GD .
NEURON, 1996, 17 (01) :9-19
[8]   Tyrosine-614, the major autophosphorylation site of the receptor tyrosine kinase HEK2, functions as multi-docking site for SH2-domain mediated interactions [J].
Hock, B ;
Böhme, B ;
Karn, T ;
Feller, S ;
Rübsamen-Waigmann, H ;
Strebhardt, K .
ONCOGENE, 1998, 17 (02) :255-260
[9]   Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells [J].
Holland, SJ ;
Gale, NW ;
Gish, GD ;
Roth, RA ;
Zhou, SY ;
Cantley, LC ;
Henkemeyer, M ;
Yancopoulos, GD ;
Pawson, T .
EMBO JOURNAL, 1997, 16 (13) :3877-3888
[10]   Protein phosphatases and the regulation of mitogen-activated protein kinase signalling [J].
Keyse, SM .
CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (02) :186-192